1226038

Tae Min Kim, M.D., Ph.D. — FEI 3028696324

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 15, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seoul (Korea (the Republic of))

Additional Details

Clinical Investigator (CI)